Medline Inc.: updates and filings

MDLNNASDAQHealthcare · Surgical & Medical Instruments & Apparatus

Price

$39.16

November 18, 2026Market cap $31.7B

What Ploutos Investor adds for Medline

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 3 fiscal years, from 2023
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 81 daysAround Feb 8, 2027 · for Q4 2026

last Nov 4, 2026next Feb 8, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Feb 25, 2026 latest annualNov 4, 2026 latest quarterly
  • Nov 18, 2026Material agreement entered, other material events
    Form8-K
  • Nov 17, 2026Filing
    FormEFFECT
  • Nov 16, 2026Filing
    FormS-1
  • Nov 13, 2026Filing (amendment)
    Form144/A
  • Nov 13, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Nov 6, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Nov 4, 2026Quarterly reportfor the period to Sep 26, 2026
    Form10-Q
  • Nov 4, 2026Results of operations
    Form8-K
  • Oct 30, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Oct 21, 2026Regulation FD disclosure
    Form8-K
  • Oct 15, 2026Officer or director change
    Form8-K
  • Aug 11, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Aug 7, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Aug 6, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Aug 5, 2026Quarterly reportfor the period to Jun 27, 2026
    Form10-Q
  • Aug 5, 2026Results of operations
    Form8-K
  • Jul 17, 2026Filing
    FormDRS
  • Jul 9, 2026Officer or director change
    Form8-K
  • Jun 12, 2026Shareholder vote
    Form8-K
  • Jun 2, 2026Material agreement entered, new material financial obligation, other material events
    Form8-K
  • May 21, 2026Filing
    FormEFFECT
  • May 21, 2026Filing
    FormS-1MEF
  • May 20, 2026Correspondence with the SEC
    FormCORRESP
  • May 20, 2026Filing
    FormS-1
  • May 15, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Dec 19, 2024.

The full analysis

What do Medline's filings show?

The filings are where every one of Medline's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.